Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000878039 | SCV001020880 | benign | KBG syndrome | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001655636 | SCV001861902 | benign | not provided | 2019-05-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000878039 | SCV002524195 | benign | KBG syndrome | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002454053 | SCV002737632 | likely benign | Inborn genetic diseases | 2017-05-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001655636 | SCV004143505 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | ANKRD11: BP4, BP7, BS1 |